Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.810
-0.030 (-0.78%)
At close: Apr 14, 2026, 4:00 PM EDT
3.810
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:10 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $251.74 million as of April 14, 2026. Its market cap has increased by 220.94% in one year.
Market Cap
251.74M
Enterprise Value
192.73M
1-Year Change
220.94%
Ranking
Category
Stock Price
$3.81
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $251.74M, a decrease of -68.70%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 253.72M | 184.83% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 269.32M |
| Compugen | 260.97M |
| Alector | 257.14M |
| Coherus Oncology | 256.31M |
| Orchestra BioMed Holdings | 251.64M |
| Minerva Neurosciences | 246.66M |
| Milestone Pharmaceuticals | 245.30M |
| Eledon Pharmaceuticals | 244.61M |